MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
8.81
-0.48
-5.17%
After Hours: 8.88 +0.07 +0.75% 19:56 03/13 EDT
OPEN
9.23
PREV CLOSE
9.29
HIGH
9.42
LOW
8.67
VOLUME
1.59M
TURNOVER
--
52 WEEK HIGH
9.94
52 WEEK LOW
3.809
MARKET CAP
520.74M
P/E (TTM)
-2.3548
1D
5D
1M
3M
1Y
5Y
1D
Vanda Advances NEREUS Launch With Direct-to-Consumer Strategy
TipRanks · 3d ago
Weekly Report: what happened at VNDA last week (0302-0306)?
Weekly Report · 4d ago
This Equinix Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga · 03/05 12:36
Vanda Pharmaceuticals Price Target Announced at $18.00/Share by Truist Securities
Dow Jones · 03/05 11:34
Truist Securities Initiates Coverage On Vanda Pharmaceuticals with Buy Rating, Announces Price Target of $18
Benzinga · 03/05 11:25
Vanda Pharmaceuticals initiated with a Buy at Truist
TipRanks · 03/05 11:11
U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva Systems
Reuters · 03/05 07:16
Vanda’s Top Brass Quietly Unload a Wave of Shares in Coordinated Sell-Off
TipRanks · 03/05 02:07
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.